227 related articles for article (PubMed ID: 7422533)
1. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
Amsterdam EA; Lee G; Awan NA; Low R; Mason DT
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533
[TBL] [Abstract][Full Text] [Related]
2. [Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate].
Baudet M; Hericotte P
Sem Hop; 1983 Mar; 59(10):683-5. PubMed ID: 6304889
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
Kośmicki MA; Malczewska B; Sadowski Z
Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
[TBL] [Abstract][Full Text] [Related]
5. Antianginal effects of pentaerythritol tetranitrate.
Arce-Gomez E; Aspe y Rosas J; Alcocer Diaz Barreiro L; Diaz Barreiro AL
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2487-91. PubMed ID: 6775303
[TBL] [Abstract][Full Text] [Related]
6. The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris.
Giles TD; Iteld BJ; Quiroz AC; Mautner RK
Chest; 1981 Aug; 80(2):142-5. PubMed ID: 7018846
[TBL] [Abstract][Full Text] [Related]
7. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
Shah PK; Shellock FG; Berman DS; Rubin SA; Singh BN; Swan HJ
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2447-50. PubMed ID: 7422534
[TBL] [Abstract][Full Text] [Related]
8. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
Volkov VS; Bratoliubov VP
Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
[TBL] [Abstract][Full Text] [Related]
9. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
Cole RE; Goldberg RI
Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503
[No Abstract] [Full Text] [Related]
10. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
Aronow S
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
[TBL] [Abstract][Full Text] [Related]
11. [The hemodynamic profile of pentaerythrityl tetranitrate].
Engelmann L; Gottschild D
Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
[TBL] [Abstract][Full Text] [Related]
12. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
[No Abstract] [Full Text] [Related]
13. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
Hansen PF; Rasmussen PA; Nyberg G
Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
[No Abstract] [Full Text] [Related]
14. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
15. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
Shellock FG; Shah PK; Berman DS; Rubin SA; Singh BN; Swan HJ
Clin Pharmacol Ther; 1980 Oct; 28(4):436-40. PubMed ID: 7408403
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the antiangina pectoris action of 2 coronary vasodilators].
Arce Gómez E; Alcocer Díaz L; Aspe Rosas JY
Arch Inst Cardiol Mex; 1975; 45(1):98-105. PubMed ID: 1093498
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
Kośmicki MA; Skorykow-Sapińska A; Sadowski Z
Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
Giard
J Sci Med Lille; 1972 Nov; 90(11):407-10. PubMed ID: 4650213
[No Abstract] [Full Text] [Related]
19. [Effect of prolonged-action pentaerythritol treatment in angina pectoris. Study base on its effects on the modifications of the electrocardiogram induced by the effort test].
Vedoya R; Nessi CT; Papakis ME; Gaguine S
Prensa Med Argent; 1966 Jul; 53(27):1468-79. PubMed ID: 5990480
[No Abstract] [Full Text] [Related]
20. Nitroglycerin prophylaxis in angina pectoris. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity.
Davidov ME; Green AM
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2473-7. PubMed ID: 6775301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
